Structure Therapeutics Announces $300 Million Private Placement Equity Financing
September 29, 2023 07:32 ET
|
Structure Therapeutics Inc.
$300 million financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors Net proceeds, along with existing cash, cash equivalents...
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
September 29, 2023 07:30 ET
|
Structure Therapeutics Inc.
GSBR-1290 shown to be generally well-tolerated with no adverse event-related discontinuations in Phase 1b multiple ascending dose study Significant weight loss at 28 days supporting once-daily...
Acute Pancreatitis Market worth $8.82 Billion by 2030 - Exclusive Report by The Insight Partners
September 18, 2023 09:10 ET
|
The Insight Partners
Pune, India, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Acute pancreatitis is a condition characterized by the inflammation of pancreas over a short period. It is a common disease and a leading cause of...
RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
September 18, 2023 05:59 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding...
Interchangeable Biosimilars Market revenue to hit USD 65 Billion by 2035, says Research Nester
September 11, 2023 07:00 ET
|
Research Nester
New York, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The global Interchangeable Biosimilars market size is slated to expand at ~ 20 % CAGR between 2023 and 2035. The market is poised to garner a revenue of...
Point of Care Diagnostics Market is Expected to Reach $75.5 billion | MarketsandMarkets.
August 30, 2023 09:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Aug. 30, 2023 (GLOBE NEWSWIRE) -- In the near future, the Point of Care Diagnostics industry is poised to undergo transformative advancements, revolutionizing healthcare by enabling rapid,...
Patient-Focused Next Generation Home Blood Test for Cardiometabolic Health Now Available to Consumers
August 28, 2023 12:08 ET
|
CardioMetaboliQ LLC
—An alarming 93 percent of US adults have less than optimal cardiometabolic health1 and many are completely unaware of their risk— —New test provides end-to-end cardiometabolic health solution, with...
GLUCOTRACK ANNOUNCES NEW VP OF MARKETING
August 28, 2023 09:00 ET
|
GlucoTrack, Inc.
Rutherford, NJ, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
RetinalGenix Technologies Inc. Announces the Addition of Fred Chasalow, Ph.D., to the Medical Advisory Board of DNA-GPS
August 28, 2023 06:35 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) today announced the addition of Fred Chasalow, Ph.D., to the...
[Latest] Global Recombinant Human Insulin Market Size/Share Worth USD 55.99 Billion by 2032 at a 8.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
August 25, 2023 16:30 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 26, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Recombinant Human Insulin Market Size, Trends and Insights By Product (Regular...